One Hundred Seventy People Now Make Your Dihydromyrcenol

In the fourth quarter of last year, Symrise wrote EUR 145 million off its terpene business.

It did not yet know who was buying it. The company's own ad hoc release, filed under Article 17 MAR on 12 January, says the charge came from "the offers received so far" in what it calls a structured bidding process.

Eight months later the answer arrived, and it was Mutares.

"What changes for a buyer when the plant stays and the parent leaves?"

What Actually Moved

On 1 September, Symrise sold AmeriTerpenes LLC to Mutares SE & Co. KGaA. Two US manufacturing sites went with it: Jacksonville, Florida and Colonels Island, Georgia.

Mutares puts the business at roughly USD 200 million in revenue and around 170 people.

The disclosed portfolio is three molecules: dihydromyrcenol, linalool and anethole, into perfumes, household products, and food and beverage flavorings. Mutares calls itself the largest North American producer of the first one.

Note the transaction mechanics, because they decide what you can still do about this. Symrise's release says the signing and closing "took place simultaneously."

There is no closing gap, no condition outstanding, no antitrust wait. Ownership changed on the day of the announcement.

The carve-out itself was finished earlier. Symrise describes an operational separation "completed over the past months," which is the tell that the entity your purchase order names may already have changed some weeks before the press release.

Price is confidential. Both parties said so in the same sentence, and Symrise added that the deal produces a non-cash disposal loss in the mid double-digit millions of euros in its 2026 statements, on top of the 145 already taken.